Table 1. Linc-ROR expression in relation to clinic opathological parameters in high-grade ovarian serous cancer patients.
Parameter | Cases (n) | Linc-ROR (mean±SD) | P-value |
---|---|---|---|
Age (years) | |||
<50 | 17 | 4.36±0.269 | |
≥50 | 22 | 4.44±0.327 | 0.432 |
FIGO stage | |||
I | 5 | 3.79±0.0767 | |
II | 15 | 4.11±0.0776 | |
III | 13 | 4.44±0.136 | |
IV | 6 | 5.06±0.256 | <0.01 |
Residual tumor diameter (cm) | |||
<1 | 30 | 4.45±0.301 | |
≥1 | 9 | 4.78±0.253 | 0.163 |
Lymph node | |||
Negative | 23 | 4.17±0.123 | |
Positive | 16 | 4.74±0.315 | <0.01 |
CA125 level (U/ml) | |||
<600 | 24 | 4.23±0.341 | |
≥600 | 15 | 4.64±0.449 | 0.259 |
Ascites | |||
<100 | 12 | 4.37±0.289 | |
≥100 | 27 | 4.57±0.367 | 0.674 |